Journal of Clinical Endocrinology & Metabolism, Vol 72, 336-343, Copyright © 1991 by Endocrine Society

ARTICLES

The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women

BB Sherwin
Department of Psychology, McGill University, Montreal, Quebec, Canada.

This study investigated the effects of various doses of estrogen and progestin on psychological functioning and sexual behavior of 48 healthy, naturally menopausal women. Subjects were tested before treatment and then randomly assigned to 1 of 4 cyclic sequential hormone regimens for 1 yr. Groups A and C received 0.625 or 1.25 mg conjugated equine estrogen (CEE), respectively, for days 1-25 and 5 mg medroxyprogesterone acetate from days 15-25. Groups B and D were given 0.625 or 1.25 mg CEE, respectively, from days 1-25 and placebo from days 15-25. The higher dose of CEE induced supraphysiological levels of plasma estrone. Plasma testosterone levels were lower in group A when blood was sampled during days 18-20 at a time when they were ingesting both 0.625 mg CEE and 5 mg medroxyprogesterone acetate (P less than 0.05), although these decreases were perhaps too trivial to have affected sexual behavior as was hypothesized. Women in group A also had more negative moods and more psychological symptomatology during treatment compared to those in group D who were receiving 1.25 mg CEE and placebo (P less than 0.01). Regardless of group, sexual desire and arousal were higher during the first 2 weeks of the treatment cycle than during week 4 when no hormones were being ingested (P less than 0.05). These findings demonstrate that the effects of progestin on the central nervous system are reflected by an increase in psychological, exclusive of sexual, symptomatology and are attenuated by a higher estrogen/progestin dose ratio.

This article has been cited by other articles:

				B. L. Parry Perimenopausal Depression Am J Psychiatry, January 1, 2008; 165(1): 23 - 27. [Full Text] [PDF]

				J. E. Potter A 60-Year-Old Woman With Sexual Difficulties JAMA, February 14, 2007; 297(6): 620 - 633. [Abstract] [Full Text] [PDF]

				J. H. Morrison, R. D. Brinton, P. J. Schmidt, and A. C. Gore Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women J. Neurosci., October 11, 2006; 26(41): 10332 - 10348. [Full Text] [PDF]

				J Bancroft The endocrinology of sexual arousal J. Endocrinol., September 1, 2005; 186(3): 411 - 427. [Abstract] [Full Text] [PDF]

				X. Zhao, H. Lorenc, H. Stephenson, Y. J. Wang, D. Witherspoon, B. Katzenellenbogen, D. Pfaff, and N. Vasudevan Thyroid hormone can increase estrogen-mediated transcription from a consensus estrogen response element in neuroblastoma cells PNAS, March 29, 2005; 102(13): 4890 - 4895. [Abstract] [Full Text] [PDF]

				Depression Obstet. Gynecol., October 1, 2004; 104(4_suppl): 49S - 55S. [Full Text] [PDF]

				K. Pazol, M. E. Wilson, and K. Wallen Medroxyprogesterone Acetate Antagonizes the Effects of Estrogen Treatment on Social and Sexual Behavior in Female Macaques J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2998 - 3006. [Abstract] [Full Text] [PDF]

				B. B Sherwin and J. McGill Oestrogen plus progestin doubles the risk of dementia in post-menopausal women Evid. Based Ment. Health, November 1, 2003; 6(4): 111 - 111. [Full Text] [PDF]

				I. Bjorn, I. Sundstrom-Poromaa, M. Bixo, S. Nyberg, G. Backstrom, and T. Backstrom Increase of Estrogen Dose Deteriorates Mood during Progestin Phase in Sequential Hormonal Therapy J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2026 - 2030. [Abstract] [Full Text] [PDF]

				D. Yokomaku, T. Numakawa, Y. Numakawa, S. Suzuki, T. Matsumoto, N. Adachi, C. Nishio, T. Taguchi, and H. Hatanaka Estrogen Enhances Depolarization-Induced Glutamate Release through Activation of Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase in Cultured Hippocampal Neurons Mol. Endocrinol., May 1, 2003; 17(5): 831 - 844. [Abstract] [Full Text] [PDF]

				B. B. Sherwin Estrogen and Cognitive Functioning in Women Endocr. Rev., April 1, 2003; 24(2): 133 - 151. [Abstract] [Full Text] [PDF]

				B. Breuer, C. Martucci, S. Wallenstein, A. Likourezos, L. S. Libow, A. Peterson, and B. Zumoff Relationship of Endogenous Levels of Sex Hormones to Cognition and Depression in Frail, Elderly Women Am J Geriatr Psychiatry, June 1, 2002; 10(3): 311 - 320. [Abstract] [Full Text] [PDF]

				M. M. Rice, A. B. Graves, S. M. McCurry, L. E. Gibbons, J. D. Bowen, W. C. McCormick, and E. B. Larson Postmenopausal Estrogen and Estrogen-Progestin Use and 2-Year Rate of Cognitive Change in a Cohort of Older Japanese American Women: The Kame Project Arch Intern Med, June 12, 2000; 160(11): 1641 - 1649. [Abstract] [Full Text] [PDF]

				A. G. Herzog Psychoneuroendocrine Aspects of Temporolimbic Epilepsy: Part I. Brain, Reproductive Steroids, and Emotions Psychosomatics, April 1, 1999; 40(2): 95 - 101. [Abstract] [Full Text]

				L. D. Dorn, S. F. Hitt, and D. Rotenstein Biopsychological and Cognitive Differences in Children With Premature vs On-Time Adrenarche Arch Pediatr Adolesc Med, February 1, 1999; 153(2): 137 - 146. [Abstract] [Full Text] [PDF]

				D. A. Charney The Psychoendocrinology of Menopause in Cross-Cultural Perspective Transcultural Psychiatry, January 1, 1996; 33(4): 413 - 434. [Abstract] [PDF]